| 1 |
26557951 | Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance. | 2015 Nov 8 |
2 |
| 2 |
23717463 | 1(OH) vitamin D3 supplementation improves the sensitivity of the immune-response during Peg-IFN/RBV therapy in chronic hepatitis C patients-case controlled trial. | 2013 |
2 |
| 3 |
23916907 | [IL28B CC genotype: a protective factor and predictor of the response to interferon treatment in chronic hepatitis C virus infection]. | 2013 Aug 11 |
1 |
| 4 |
21871023 | Ribavirin downmodulates inducible costimulator on CD4+ T cells and their interleukin-10 secretion to assist in hepatitis C virus clearance. | 2012 Apr |
7 |
| 5 |
22848715 | Ribavirin exerts differential effects on functions of Cd4+ Th1, Th2, and regulatory T cell clones in hepatitis C. | 2012 |
4 |
| 6 |
20483710 | Increased Th1, Th17 and pro-fibrotic responses in hepatitis C-infected patients are down-regulated after 12 weeks of treatment with pegylated interferon plus ribavirin. | 2010 Jun |
2 |
| 7 |
18248380 | Changes in the Th1/Th2 ratio during a 24-week course of an interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C. | 2008 Aug |
2 |
| 8 |
19102366 | Ribavirin priming in patients with chronic hepatitis C and normal ALT: a pilot study. | 2008 Sep-Oct |
2 |
| 9 |
17370474 | [Cutaneous sarcoidosis during pegylated interferon alpha and ribavirin treatment of chronic hepatitis C--a case report]. | 2007 Jan |
1 |
| 10 |
16377237 | Th1 response during ribavirin and interferon-alpha combination therapy in chronic hepatitis C. | 2006 Feb |
5 |
| 11 |
16803610 | Sustained virological response to peginterferon plus ribavirin in chronic hepatitis C genotype 1 patients is associated with a persistent Th1 immune response. | 2006 Jul 1 |
1 |
| 12 |
17074015 | Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C. | 2006 Dec |
1 |
| 13 |
15505595 | Effects of ribavirin on cytokine production of recall antigens and phytohemaglutinin-stimulated peripheral blood mononuclear cells. (Inhibitory effects of ribavirin on cytokine production). | 2004 Jul-Sep |
1 |
| 14 |
12659664 | Ribavirin in cancer immunotherapies: controlling nitric oxide augments cytotoxic lymphocyte function. | 2003 Jan-Feb |
4 |
| 15 |
12673448 | Immunological predictors of different responses to combination therapy with interferon alpha and ribavirin in patients with chronic hepatitis C. | 2003 |
1 |
| 16 |
11903249 | Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases. | 2002 Feb |
2 |
| 17 |
12642684 | Ribavirin in cancer immunotherapies: controlling nitric oxide helps generate cytotoxic lymphocyte. | 2002 Nov-Dec |
4 |
| 18 |
12825459 | Ribavirin: recent insights into antiviral mechanisms of action. | 2001 Sep |
1 |
| 19 |
11030438 | Combination treatment for chronic hepatitis C: what is the role of ribavirin? | 2000 Jul-Aug |
1 |
| 20 |
10622579 | Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C. | 1999 |
1 |